Novavax Aktie
WKN DE: A2PKMZ / ISIN: US6700024010
08.08.2022 22:05:00
|
Novavax Inc. Q2 Loss increases, misses estimates
(RTTNews) - Novavax Inc. (NVAX) revealed Loss for its second quarter that increased from last year and missed the Street estimates.
The company's earnings came in at -$510.49 million, or -$6.53 per share. This compares with -$352.32 million, or -$4.75 per share, in last year's second quarter.
Analysts on average had expected the company to earn $5.50 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 37.6% to $185.93 million from $298.02 million last year.
Novavax Inc. earnings at a glance (GAAP) :
-Earnings (Q2): -$510.49 Mln. vs. -$352.32 Mln. last year. -EPS (Q2): -$6.53 vs. -$4.75 last year. -Analyst Estimate: $5.50 -Revenue (Q2): $185.93 Mln vs. $298.02 Mln last year.
-Guidance: Full year revenue guidance: $2.0 - $2.3 Bln

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novavax Inc.mehr Nachrichten
26.02.25 |
Ausblick: Novavax vermeldet Zahlen zum jüngsten Quartal (finanzen.net) | |
11.11.24 |
Ausblick: Novavax präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) |
Analysen zu Novavax Inc.mehr Analysen
Aktien in diesem Artikel
Novavax Inc. | 5,80 | -5,91% |
|